MRD / Regn No. : THBC\23-24\06573 Date : 18/06/2026
Patient Name : Bhavesh Kothari Age & Gender : 59 Yrs. / Male
Contact No. : 8779285602 UHID :
Ht / Wt / BMI : 175.26 / 80.95 / 26.35 BP S / BP D : 121 / 72
Allergies : NONE Referred By :
   
Problem List : T2DM (20/Feb/2015) | DYSLIPIDEMIA (20/Feb/2017) | HTN (20/Feb/2017) |
Subjective : T2DM SINCE 2015,HTN/DYSLIPIDEMIA SINCE 2017,WT LOSS GOOD,2 MTHS AGO CGM - EAG 6.7% - SO LAB WOULD PROBABLY HAVE BEEN 7.7%,DISCONTINUED MOUNJARO / CGM USE,LOT OF TRAVEL,LOWEST 77 - NOW 80 KGS,NEPHROLOGIST - DR RUJU GALA
Objective : 17-JUN-2026 REPORTS,HB-16.5/ HBA1C-9.5%,VITD-12.1,VITB12-254,HSCRP-0.72,TC-136/ TG-225/ LDL-77.2/ HDL-29,ALT-26.4/ AST-27.8,NA-136.6/ K-3.86/ CL-97.5,CR-0.6,URIC ACID-4.2,T3-75/ T4-8.35/ TSH-3.731,EGFR-112,UACR-121.9
S# Generic (Trade) Name Route Dosage Usage Duration
1 JUPIROS CV 10 ORAL 0-0-1 AD
3 MTHS
2 STARPRESS XL 50 ORAL 0-0-1 AD
3 MTHS
3 TABLET DAPAGLIFLOZIN (10MG)
UDAPA 10 MG
ORAL 0-1-0 AL
3 MTHS
4 EZEDOC 10 MG ORAL 0-0-1 AD
3 MTHS
5 TABLET TELMISARTAN
TELVAS 40 MG
ORAL 1-0-0 AL
3 MTHS
6 LYVELSA 20 MG ORAL 1-0-0 ABF
3 MTHS
7 AMITRYN 10 MG ORAL 0-0-1 EVENING 7 PM
3 MTHS
8 TABLET DIVALPROEX
DAYO 250 MG
ORAL 1-0-0 ABF
3 MTHS
9 IVABRAD 5 MG ORAL 1-0-1 ABF/ AD
3 MTHS
10 GLIMISAVE M2 ORAL 1-0-1 BBF / BD
3 MTHS
11 INJ OZEMPIC 1 MG SC 1/WEEKLY ANYTIME OF DAY
4 WEEKS
12 INJ OZEMPIC 1.7 MG SC 1/WEEK ANYTIME OF DAY
4 WEEKS
13 INJ OZEMPIC 2.4 MG SC 1/WEEK ANYTIME OF DAY
4 WEEKS
14 TAB GLUCOBAY 50 MG ORAL TDS WITH MEALS
3 MTHS
15 EUREPA 1 MG ORAL 1-0-1 BBF/ BD
3 MTHS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 18/Sep/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C > 3 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: